Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Structural brain lesions in inflammatory bowel disease.
Caregiving in Multiple Sclerosis and Quality of Life: A Meta-synthesis of Qualitative Research.
Gait and six-minute walk performance in persons with multiple sclerosis.
Fluoxetine prevents oligodendrocyte cell death by inhibiting microglia activation after spinal cord injury.
HSV1 and 2 Detection in the CSF of Multiple Sclerosis Patients by Real-time PCR.
Misoprostol as a Therapeutic Option for Trigeminal Neuralgia in Patients with Multiple Sclerosis.
Theiler's murine encephalomyelitis virus induced phenotype switch of microglia in vitro.
Contextualized perceptions of movement as a source of expanded insight: People with multiple sclerosis' experience with physiotherapy.
MRI measures should be a primary outcome endpoint in Phase III randomized, controlled trials in multiple sclerosis: Yes.
Simvastatin in Relapsing Remitting Multiple Sclerosis (RRMS) Patients Using Avonex Compared to Placebo (irmsrct)
The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool.
Multiple sclerosis: Sodium channel blocker protects axons in MS models.
The co-occurrence of pain and depression in adults with multiple sclerosis.
Discovery of A-971432, an Orally Bioavailable Selective Sphingosine-1-Phosphate Receptor 5 (S1P5) Agonists for the Potential Treatment of Neurodegenerative Disorders.
Advances in the management of MS symptoms: real-life evidence.
The clinico-radiological paradox in multiple sclerosis: novel implications of lesion size.
Effects of Bacille Calmette-Guerin after the first demyelinating event in the CNS.
Clarification on neuromuscular conditions in careers article.
Can the irradiated brain be salvaged by oligodendrocyte precursor transplantation?
Accuracy of a custom physical activity and knee angle measurement sensor system for patients with neuromuscular disorders and gait abnormalities.
Understanding Biomarkers of Neurodegeneration: Ultrasensitive detection techniques pave the way for mechanistic understanding.
Long-term treatment risks in multiple sclerosis: risk knowledge and risk perception in a large cohort of mitoxantrone-treated patients.
Role of SFB in autoimmune arthritis: An example of regulation of autoreactive T cell sensitivity in the gut.
New Clues to Link Between MS Drug Tysabri and Rare Brain Disease
PET imaging in multiple sclerosis.

Pages